Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Clinical trial NCT00030498 · COMPLETED
Trial details
- NCT number
- NCT00030498
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2007-07-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.